RBM39 and colorectal cancer: Because MORC2 promotes development of an aggressive colorectal cancer phenotype [16] and RBM39 increases the survival rate and anchoring-independent growth of colorectal cancer cells [55], further study on the mechanism of RBM39 upregulation by MORC2 would be vital for therapy of patients with colorectal cancer.